Copy number was prognostic even for genes in which mutations were not linked with outcome: for instance, while mutations in PIK3CA were never informative, the copy number of PIK3CA was associated with outcome in breast, colorectal, glioma, lung-squamous, pancreas, and prostate cancers (Figure 2B and D). This evidence concerns the gene PIK3CA and Familial prostate cancer.